Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Traxion Sab De Cv Ord Shs GRPOF

Grupo Traxion SAB de CV is a Mexico-based company engaged in the transportation sector. The Company provides logistics services within eight business areas: Fright, including intermodal and multimodal services, door-to-door, national and cross-border distribution, among others; Integrated logistics, including logistics management, aerial and maritime services and custom transportation support... see more

PINL:GRPOF - Post Discussion

Traxion Sab De Cv Ord Shs > LeafRider, you ignorant pumper/liar
View:
Post by itsthecbdstupid on Jan 30, 2019 1:03pm

LeafRider, you ignorant pumper/liar

"Tetra Bio-Pharma Receives Health Canada Phase 3 Clinical Trial Approval For Smokable Dried Cannabis Prescription Drug. Feb 4, 2018." https://tetrabiopharma.com/investors/press-releases/press-release-details/2018/Tetra-Bio-Pharma-Receives-Health-Canada-Phase-3-Clinical-Trial-Approval-For-Smokable-Dried-Cannabis-Prescription-Drug/default.aspx What happens in phase III? "Phase III of a clinical trial usually involves up to 3,000 participants who have the condition that the new medication is meant to treat. Trials in this phase can last for several years." https://www.healthline.com/health/clinical-trial-phases#phase-ii "Phase III trials are the most expensive, time-consuming and difficult trials to design and run, especially in therapies for chronic medical conditions." "While not required in all cases, it is typically expected that there be at least two successful Phase III trials, demonstrating a drug's safety and efficacy, in order to obtain approval from the appropriate regulatory agencies such as FDA (USA), or the EMA (European Union)." Success rate "As of 2010, about 50% of drug candidates either fail during the Phase III trial or are rejected by the national regulatory agency." Overall cost "The entire process of developing a drug from preclinical research to marketing can take approximately 12 to 18 years and often costs well over $1 billion" https://en.wikipedia.org/wiki/Phases_of_clinical_research#Phase_III
Comment by Hammertown87 on Jan 30, 2019 1:05pm
Fake copy and paste article by itsthecbdstupid
Comment by frobin2 on Jan 30, 2019 1:07pm
https://clinicaltrials.gov/ct2/show/NCT03339622?term=ppp001&rank=2 There's the official study - where are these 3,000 patients you speak of? Because according to this study from a government web site, it's 946. That's weird... lol Get outta here lol Haven't seen ya until the stock rose up like crazy. Crazy timing huh? lol
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities